Standard Social Media Practices Are Risky For Big Pharma

As the pharma industry comes late to social media, FDA guidance and regulation of pharma’s efforts illustrate difficulties industry may face.

September 26, 2014

Law360, New York (September 26, 2014, 10:08 AM ET) --

The days of patients relying solely on family physicians for health care information are long gone. As with many things, when we need information about an illness or a medical condition, we turn to "the Google." And though most online health queries begin at a search engine, a not-insignificant number start somewhere else, such as Wikipedia. Those who are Internet-savvy tend to be avid social media users, spending more time with their social networks than on email, especially with their Facebook friends. An estimated 200,000 people are likely to start there if they have a question.

The articles on our website include some of the publications and papers authored by our attorneys, both before and after they joined our firm. The content of these articles should not be taken as legal advice. The views and opinions expressed in this article are those of the author(s) and do not necessarily reflect the views or official position of Robins Kaplan LLP.

Disclaimer

Sharon E. Roberg-Perez, Ph.D.

Partner

Co-Chair, Diversity Committee

Related Publications

November 2020
Explaining the Almost Unexplainable
David Prange, Benjamen Linden, Vivek Biswas - Intellectual Property Magazine
October 2, 2020
Does an AB Rating Fill Out a Skinny Label?
Jeffrey Alan Hovden, Oren D. Langer
September 22, 2020
Herbal Patent Protection
Shui Li - 闻宁阁 American Intellectual Property
August 26, 2020
INSIGHT: Avoiding Trade Secret Claims After Seeing a Competitor’s Crown Jewels
Jake Holdreith, David Prange, Emily Tremblay - Bloomberg Law
Back to Top